XM tillhandahåller inte tjänster till personer bosatta i USA.

U.S. Acuity Brands, CSG Systems International, Nuvation Bio



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>U.S. RESEARCH ROUNDUP-Acuity Brands, CSG Systems International, Nuvation Bio</title></head><body>

March 27 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Acuity Brands, CSG Systems International, and Nuvation Bio, on Wednesday.


HIGHLIGHTS

* Acuity Brands Inc AYI.N: Baird raises target price to $286 from $236

* CSG Systems International CSGS.O: RBC initiates coverage with outperform rating

* Lenz Therapeutics Inc LENZ.O: Piper Sandler initiates coverage with overweight rating

* Nuvation Bio Inc NUVB.N: Jefferies raises to buy from hold

* Transdigm Group Inc TDG.N: JP Morgan raises target price to $1,175 from $1,050


Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.


* Abbvie Inc ABBV.N: Barclays raises target price to $195 from $185

* Acuity Brands Inc AYI.N: Baird raises target price to $286 from $236

* Acumen Pharmaceuticals Inc ABOS.O: BTIG cuts target price to $11 from $22

* American Battery Technology Co ABAT.O: Northland Capital initiates with outperform rating; PT $6

* Americold Realty Trust Inc COLD.N: Barclays cuts target price to $25 from $32

* Ameris Bancorp ABCB.O: Piper Sandler cuts target price to $55 from $60

* Annexon Inc ANNX.O: Jefferies raises target price to $10 from $8.5

* Annexon Inc ANNX.O: Wells Fargo raises target price to $12 from $11

* Antero Resources Corp AR.N: JP Morgan raises target price to $32 from $30

* Aprea Therapeutics Inc APRE.O: Wedbush raises target price to $11 from $9

* Arch Resources Inc ARCH.N: Jefferies cuts target price to $185 from $190

* Bakkt Holdings Inc BKKT.N: Citigroup cuts target price to $0.3 from $0.5

* Bancfirst Corp BANF.O: Piper Sandler cuts target price to $78 from $80

* Bank7 Corp BSVN.O: Piper Sandler cuts target price to $33 from $37

* Berry Global Group Inc BERY.N: Truist Securities cuts target price to $68 from $75

* Berry Global Group Inc BERY.N: Truist Securities cuts to hold from buy

* Bioatla, Inc. BCAB.O: H.C. Wainwright cuts target price to $7 from $10

* Blackline Inc BL.O: Citigroup raises target price to $66 from $57

* Bloom Energy Corp BE.N: Susquehanna cuts target price to $16 from $18

* Bluebird Bio Inc BLUE.O: BofA Global Research cuts price objective to $4 from $5

* Bluebird Bio Inc BLUE.O: Raymond James cuts target price to $7 from $13

* Bluebird Bio Inc BLUE.O: Wedbush raises target price to $1.72 from $1.68

* Boston Properties Inc BXP.N: Barclays cuts target price to $66 from $67

* Cabot Corp CBT.N: Mizuho initiates coverage with buy rating; target price $104

* Capital Bancorp Inc CBNK.O: Piper Sandler cuts target price to $25 from $27

* Carter Bankshares Inc CARE.O: Piper Sandler cuts target price to $13 from $14

* Celsius Holdings Inc CELH.O: Jefferies raises target price to $107 from $105

* ChampionX Corp CHX.O: Citigroup raises target price to $40 from $39

* Cousins Properties Inc CUZ.N: Barclays cuts target price to $25 from $29

* Crown Holdings Inc CCK.N: Truist Securities cuts target price to $88 from $100

* Crown Holdings Inc CCK.N: Truist Securities cuts to hold from buy

* CSG Systems International CSGS.O: RBC initiates coverage with outperform rating

* CSG Systems International CSGS.O: RBC initiates target price $61

* Darden Restaurants Inc DRI.N: Truist Securities cuts target price to $185 from $190

* Delcath Systems, Inc. DCTH.O: H.C. Wainwright raises target price to $20 from $18

* Direct Digital Holdings Inc DRCT.O: Benchmark cuts target price to $23 from $30

* Disney DIS.N: UBS raises target price to $140 from $120

* Doordash Inc DASH.O: Truist Securities raises target price to $155 from $140

* Dow Inc DOW.N: Jefferies raises target price to $60 from $56

* Draftkings Inc DKNG.O: Needham raises target price to $58 from $54

* Eagle Bancorp Inc EGBN.O: Piper Sandler cuts target price to $25 from $28

* Electronic Arts Inc EA.O: UBS cuts target price to $143 from $146

* Enterprise Products Partners LP EPD.N: Mizuho raises target price to $34 from $33

* Finance of America Companies Inc FOA.N: UBS raises target price to $1.5 from $1.4

* First Community Bankshares Inc FCBC.O: Piper Sandler cuts target price to $33 from $37

* First Community Corp (South Carolina) FCCO.O: Piper Sandler cuts PT to $19 from $21

* First Guaranty Bancshares Inc FGBI.O: Piper Sandler cuts target price to $10 from $10.5

* Gamestop Corp GME.N: Wedbush cuts target price to $5.60 from $6

* GE GE.N: Wells Fargo raises target price to $200 from $177

* General Electric Company GE.N: Wells Fargo raises target price to $200 from $177

* Getty Realty Corp GTY.N: JP Morgan cuts target price to $31 from $32

* GoDaddy Inc GDDY.N: Raymond James resumes coverage with strong buy rating; PT $150

* Huntington Ingalls Industries HII.N: BofA Global Research ups price objective to $300 from $250

* Ideal Power Inc IPWR.O: Benchmark cuts target price to $14 from $18

* Immunome Inc IMNM.O: Leerink Partners cuts target price to $38 from $40

* Independent Bank Group Inc IBTX.O: Piper Sandler cuts target price to $48 from $53

* Integral Ad Science Holding Corp IAS.O: Evercore ISI cuts target price to $16 from $22

* International Flavors & Fragrances IFF.N: Morgan Stanley raises PT to $96 from $89

* Intrusion Inc. INTZ.O: H.C. Wainwright raises target price to $3 from $0.5

* JetBlue Airways JBLU.O: Barclays reinstates coverage with underweight rating; PT $6

* Keurig DR Pepper Inc KDP.O: Jefferies cuts target price to $35 from $37

* Korro Bio Inc KRRO.O: RBC raises target price to $90 from $70

* Krispy Kreme Inc DNUT.O: Citigroup raises target price to $19 from $14

* Legalzoom.com Inc LZ.O: Raymond James resumes coverage with market perform rating

* Leidos Holdings LDOS.N: BofA Global Research raises price objective to $145 from $125

* Lenz Therapeutics Inc LENZ.O: Piper Sandler initiates coverage with overweight rating

* Lenz Therapeutics Inc LENZ.O: Piper Sandler initiates target price $28

* Levi Strauss & Co LEVI.N: Telsey Advisory Group raises target price to $22 from $18

* Lifeway Foods Inc LWAY.O: Noble Capital cuts to market perform from outperform

* Lowe's Companies Inc LOW.N: D.A. Davidson cuts to neutral from buy

* Mastercard Inc MA.N: Evercore ISI raises target price to $545 from $530

* McCormick & Company Inc MKC.N: Bernstein raises target price to $92 from $84

* McCormick & Company Inc MKC.N: BofA Global Research ups price objective to $86 from $82

* McCormick & Company Inc MKC.N: Citigroup raises target price to $68 from $60

* McCormick & Company Inc MKC.N: Jefferies raises target price to $77 from $67

* McCormick & Company Inc MKC.N: Stifel raises target price to $75 from $70

* McCormick & Company Inc MKC.N: TD Cowen raises target price to $75 from $67

* McCormick MKC.N: Deutsche Bank raises target price to $74 from $72

* Merck & Co Inc MRK.N: Jefferies raises target price to $145 from $140

* Merck & Co Inc MRK.N: Truist Securities raises target price to $142 from $139

* Merck & Co Inc MRK.N: Wells Fargo raises target price to $135 from $130

* Nasdaq Inc NDAQ.O: Goldman Sachs raises to buy from neutral

* Ncino Inc NCNO.O: BofA Global Research raises price objective to $38 from $34

* Ncino Inc NCNO.O: Morgan Stanley raises target price to $30 from $27

* Ncino Inc NCNO.O: Morgan Stanley raises target price to $30.00 from $27.00

* Ncino Inc NCNO.O: Needham raises target price to $42 from $40

* Netflix Inc NFLX.O: Wedbush raises target price to $725 from $615

* Netflix Inc NFLX.O: Wedbush removes stock from its best ideas list

* Nexpoint Real Estate Finance Inc NREF.N: Raymond James cuts PT to $17 from $19

* Novocure Limited NVCR.O: H.C. Wainwright raises target price to $24 from $22

* Nutanix Inc NTNX.O: Morgan Stanley raises target price to $63 from $58

* Nuvation Bio Inc NUVB.N: Jefferies raises target price to $10 from $1.4

* Nuvation Bio Inc NUVB.N: Jefferies raises to buy from hold

* Outlook Therapeutics Inc OTLK.O: BTIG raises to buy from neutral

* Praxis Precision Medicines Inc PRAX.O: Jefferies raises PT to $128 from $75

* Primis Financial Corp FRST.O: Piper Sandler cuts target price to $14 from $15

* Progress Software Corp PRGS.O: JP Morgan cuts target price to $63 from $65

* Progressive Corp PGR.N: TD Cowen raises target price to $197 from $184

* Prologis Inc PLD.N: Barclays cuts target price to $141 from $153

* Provident Financial Services Inc PFS.N: D.A. Davidson cuts target price by $2 to $15

* PVH Corp PVH.N: BofA Global Research raises price objective to $156 from $135

* Realty Income Corp O.N: JP Morgan cuts target price to $60 from $64

* Regions Financial Corp RF.N: Piper Sandler raises target price to $20 from $19.5

* Royal Gold Inc RGLD.O: BMO raises target price to $158 from $148

* Royal Gold Inc RGLD.O: BMO raises to outperform from market perform

* Salesforce Inc CRM.N: TD Cowen raises target price to $330 from $315

* Sandy Spring Bancorp Inc SASR.O: Piper Sandler cuts target price to $24 from $27

* Servisfirst Bancshares Inc SFBS.N: Piper Sandler cuts target price to $63 from $64

* Shore Bancshares Inc SHBI.O: Piper Sandler cuts target price to $14 from $15

* Sirius XM Holdings Inc SIRI.O: Benchmark cuts target price to $6.5 from $7

* Southern First Bancshares Inc SFST.O: Piper Sandler cuts target price to $40 from $44

* Spirit Airlines SAVE.N: Barclays reinstates with underweight rating; target price $4

* SPX Technologies Inc SPXC.N: UBS raises target price to $126 from $90

* Squarespace Inc SQSP.N: Raymond James resumes coverage with outperform rating; PT $40

* Stock Yards Bancorp Inc SYBT.O: Piper Sandler cuts target price to $50 from $52

* TD Synnex Corp SNX.N: Barclays raises target price to $118 from $111

* TD Synnex Corp SNX.N: Raymond James raises target price to $125 from $120

* TD Synnex Corp SNX.N: RBC raises target price to $118 from $110

* TD Synnex Corp SNX.N: UBS raises target price to $115 from $107

* Terns Pharmaceuticals Inc TERN.O: UBS cuts target price to $18 from $19

* Tesla Inc TSLA.O: Citigroup cuts target price to $196 from $224

* Third Harmonic Bio Inc THRD.O: Jefferies raises target price to $8.1 from $3.6

* Townebank TOWN.O: Piper Sandler cuts target price to $32 from $33

* Transdigm Group Inc TDG.N: JP Morgan raises target price to $1,175 from $1,050

* Travere Therapeutics Inc TVTX.O: Guggenheim cuts to neutral from buy

* Tronox Holdings Plc TROX.N: Deutsche Bank raises target price to $20 from $17

* Uber Technologies Inc UBER.N: Moffettnathanson raises target price to $92 from $76

* Uber Technologies Inc UBER.N: Truist Securities raises target price to $94 from $90

* United Bankshares Inc UBSI.O: Piper Sandler cuts target price to $37 from $39

* United Parcel Service UPS.N: Morgan Stanley raises target price to $100.00 from $95.00

* United Therapeutics Corp UTHR.O: Leerink Partners raises PT to $335 from $330

* UPS UPS.N: BMO raises target price to $165 from $160

* UPS UPS.N: BofA Global Research cuts price objective to $158 from $164

* UPS UPS.N: Jefferies cuts target price to $175 from $180

* UPS UPS.N: Morgan Stanley raises target price to $100 from $95

* Vera Therapeutics Inc VERA.O: Guggenheim raises target price to $56 from $27

* Viking Therapeutics Inc VKTX.O: Leerink Partners raises PT to $115 from $105

* Viking Therapeutics Inc VKTX.O: Oppenheimer raises target price to $138 from $116

* Virtus Investment Partners Inc VRTS.N: Piper Sandler raises PT to $275 from $264

* Visa Inc V.N: Evercore ISI raises target price to $335 from $325

* Vital Farms Inc VITL.O: D.A. Davidson raises target price to $28

* Wells Fargo & Co WFC.N: KBW cuts to market perform from outperform

* Wells Fargo & Co WFC.N: KBW raises target price to $62 from $56

* Wesbanco Inc WSBC.O: Piper Sandler cuts target price to $30 from $32

* Xcel Brands Inc XELB.O: Noble Capital cuts target price to $3 from $3.5

* Yelp Inc YELP.N: Raymond James initiates coverage with market perform rating

* Ziprecruiter Inc ZIP.N: Raymond James resumes coverage with market perform rating


(Compiled by Bengaluru Newsroom)

</body></html>

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.